Symcel

About:

Symcel develops and markets analytical instrumentations that fulfil an unmet need for cell biological research and development

Website: https://symcel.com/

Twitter/X: symcel

Top Investors: EASME - EU Executive Agency for SMEs, Sting

Description:

Symcel provides a novel cellbased assay tool for real time cellular bioenergetic measurements. Symcel develops and markets analytical instrumentations that fulfill an unmet need for cell biological research and development, within R&D departments of Life Science industry, as well as academic research laboratories. Our solution is a fast label-free assay technology providing real-time continuous data monitoring of cell metabolism.

Total Funding Amount:

3.62M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Spånga, Skane Lan, Sweden

Founded Date:

2004-01-01

Contact Email:

info(AT)symcel.com

Founders:

Dan Hallen, Ingemar Wadso

Number of Employees:

1-10

Last Funding Date:

2017-11-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai